S2 E2 — How COVID-19 is changing patient management and clinical trials
Send us Fan Mail Manal Abdelmalek joins the Surfers to describe long-term changes in patient management that improved diagnostic and telecommunication technologies can drive in response to new COVID-1...
14 Jan 202150min
S2 E1.3 - Challenges and Big Ideas for NAFLD/NASH Patient Diagnosis and Treatment in the Post-Second Wave World
Send us Fan Mail Question: If NALFD patients have poorer COVID-19 prognoses, how can we use this fact to drive broader population-based screening? This conversation asks a two-part question: How do w...
9 Jan 202123min
S2 E1.2 Successfully Managing Clinical Trials during COVID-19's Second Wave
Send us Fan Mail The COVID-19 conversation continues with the group focusing on challenges in clinical trial execution and how innovative logistics and consistent education can lessen or overcome them...
9 Jan 202121min
S2 E1.1 - How Recent COVID-19 News Affects NAFLD and NASH Patients
Send us Fan Mail Manal Abdelmalek joins the Surfers to consider the three most important COVID-19 stories today. The conversation focuses on the British variant, the new vaccines, and the physical an...
9 Jan 202123min
S2 E1 - How Will COVID-19 Affect the Fatty Liver Community in 2021?
Send us Fan Mail Manal Abdelmalek joins the Surfers to discuss how recent COVID-19 news might affect Fatty Liver patients and what the medical profession and BioPharma companies can do to support pati...
7 Jan 20211h 10min
44.4 2020 Year In Review: How Patients and Patient Advocates reacted to a year of lows and high
Send us Fan Mail Wayne Eskridge describes how hope fell and then rose as patients did not receive the drug approval they expected but then learned about exciting paths for new agents and non-invasive ...
1 Jan 202123min
44.3 2020 Year In Review: Revisiting the "MAFLD vs. NAFLD" debate
Send us Fan Mail Louise Campbell questions the implication of APASL and ALEH endorsing "MAFLD" as Fatty Liver Disease nomenclature and Stephen Harrison discusses behind-the-scenes activities to resolv...
1 Jan 202118min
44.2 2020 Year In Review: Fatty Liver Disease Enters the Public Dialogue in Germany
Send us Fan Mail Joern Schattenberg discusses the public health implications of German newspapers beginning to discuss Fatty Liver Disease For Joern Schattenberg, reading about Non-Alcoholic Fatty Li...
1 Jan 202121min
